NCT06106776View on ClinicalTrials.gov

CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

Not yet recruitingOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

November 2, 2024

Study Completion Date

January 31, 2026

Conditions
Lymphoma
Interventions
DRUG

Chimeric Antigen Receptor

This study will evaluate the incidence of cardiac dysfunction at 7 days and 1 month after chimeric antigen receptor-T cell infusion (tisagenlecleucel, axicabtagene ciloleucel e brexucabtagene autoleucel).

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06106776 - CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study | Biotech Hunter | Biotech Hunter